TY  - CHAP
M1  - Book, Section
TI  - Sickle Cell Disease
A1  - Hagemann, Tracy M.
A1  - Lewis, Teresa V.
A2  - Chisholm-Burns, Marie A.
A2  - Schwinghammer, Terry L.
A2  - Malone, Patrick M.
A2  - Kolesar, Jill M.
A2  - Bookstaver, P. Brandon
A2  - Lee, Kelly C.
PY  - 2022
T2  - Pharmacotherapy Principles & Practice, 6e
AB  - LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Explain  the  underlying  causes  of  sickle  cell  disease  (SCD)  and  their  relationship  to  patient  signs  and  symptoms.Identify  the  typical  characteristics  of  SCD  as  well  as  symptoms  that  indicate  complicated  disease.Identify  the  desired  therapeutic  outcomes  for  patients  with  SCD.Recommend  appropriate  pharmacotherapy  and  nonpharmacotherapy  interventions  for  patients  with  SCD.Recognize  when  chronic  maintenance  therapy  is  indicated  for  a  patient  with  SCD.Describe  the  components  of  a  monitoring  plan  to  assess  effectiveness  and  adverse  effects  of  pharmacotherapy  for  SCD.Educate  patients  about  the  disease  state,  appropriate  therapy,  and  drug  therapy  required  for  effective  treatment  and  prevention  of  complications.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/10/10
UR  - ppp.mhmedical.com/content.aspx?aid=1187026256
ER  -